
CDT P/E Ratio
P/E Ratio as of Jun 13, 2025: -0.01
Average-0.0125
Median-0.0100
Minimum-0.0200
Maximum-0.0100
-0.01
Past Month+0.01 (50.00%)
The P/E ratio for CDT is -0.01 as of Jun 13, 2025. This represents a decrease of -98.96% compared to its 12-month average P/E ratio of -0.96. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Conduit Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Conduit Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Conduit Pharmaceuticals Inc to industry peers.
Conduit Pharmaceuticals Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Conduit Pharmaceuticals Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Conduit Pharmaceuticals Inc to industry peers.
CDT P/E Ratio Insights
See Conduit Pharmaceuticals Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CDT
Order type
Buy in
Order amount
Est. shares
0 shares
CDT P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $3.94 | -0.01 |
May 1, 2025 | $8.40 | -0.03 |
Apr 1, 2025 | $10.8315 | -0.04 |
Mar 3, 2025 | $17.40 | -0.05 |
Feb 3, 2025 | $33.00 | -0.10 |
Jan 2, 2025 | $113.55 | -0.36 |
CDT End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -0.01 | -96.88% |
2024 | -0.32 | -100.05% |
2023 | 648.15 | — |
FAQs About Conduit Pharmaceuticals Inc (CDT) P/E ratio
The latest P/E ratio of CDT is -0.01, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Conduit Pharmaceuticals Inc’s last 12-month average P/E ratio is -0.96, compared to its current P/E ratio of -0.01. This reflects a decrease of -98.96%.
Conduit Pharmaceuticals Inc’s current P/E ratio of -0.01 is lower than its last 12-month average P/E of -0.96. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Conduit Pharmaceuticals Inc’s average P/E ratio over the last 3 years is 55.59. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Conduit Pharmaceuticals Inc’s average P/E ratio over the last 5 years is 33.35. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.